Editorial : infliximab trough levels and histological healing in ulcerative colitis—a step towards personalised biologic therapy
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Alimentary Pharmacology & Therapeutics - 47(2018), 6, Seite 855-856 |
Beteiligte Personen: |
Lobaton, T. [VerfasserIn] |
---|
BKL: |
---|
Anmerkungen: |
Copyright © 2018 John Wiley & Sons Ltd |
---|
Umfang: |
2 |
---|
doi: |
10.1111/apt.14532 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY002326582 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WLY002326582 | ||
003 | DE-627 | ||
005 | 20230307114542.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230210s2018 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1111/apt.14532 |2 doi | |
028 | 5 | 2 | |a APT_APT14532.xml |
035 | |a (DE-627)WLY002326582 | ||
035 | |a (WILEY)APT14532 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.38 |2 bkl | ||
100 | 1 | |a Lobaton, T. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Editorial |b infliximab trough levels and histological healing in ulcerative colitis—a step towards personalised biologic therapy |
264 | 1 | |c 2018 | |
300 | |a 2 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Copyright © 2018 John Wiley & Sons Ltd | ||
700 | 1 | |a De Vos, M. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Alimentary Pharmacology & Therapeutics |g 47(2018), 6, Seite 855-856 |w (DE-627)WLY002324040 |x 13652036 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2018 |g number:6 |g pages:855-856 |g extent:2 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-ASE | ||
936 | b | k | |a 44.38 |q ASE |
951 | |a AR | ||
952 | |d 47 |j 2018 |e 6 |h 855-856 |g 2 |